Roos van Schuijlenburg

Author

Leiden University Medical Center ORCID

Also Known As

R. van Schuijlenburg, Roos Van Schuijlenburg, Roos van Schuijlenburg

Publications

339

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Erasmus MC

About

Roos van Schuijlenburg is an author at Leiden University Medical Center specializing in medicine, vaccination, and parasitology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	194
2	Immunology	2	2	175
3	Cell Biology	1	1	35
4	Pharmacology	1	1	19
5	Drug Resistance	1	1	19

Roos van Schuijlenburg

Publications

319

Citations

H-Index

Page 1

	Year	Citations
A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics Marijke C. C. Langenberg, Marie-Astrid Hoogerwerf, Jan Pieter R. Koopman, Nature Medicine VaccinationParasitic DiseaseParasitic ProtozoaImmunologySchistosomiasis	2020	140
Plasmodium sporozoites induce regulatory macrophages Béatrice M. F. Winkel, Leonard R. Pelgrom, Roos van Schuijlenburg, PLoS Pathogens Human ApcsMalariaImmunologyImmune RegulationCell Death	2020	35
Latent CMV Infection Is Associated With Lower Influenza Virus-Specific Memory T-Cell Frequencies, but Not With an Impaired T-Cell Response to Acute Influenza Virus Infection Sara P. H. van den Berg, Josien Lanfermeijer, Ronald Jacobi, Frontiers in Immunology	2021	23
Antigen-based diagnosis of Schistosoma infection in travellers: a prospective study Miriam Casacuberta-Partal, Jacqueline J. Janse, Roos van Schuijlenburg, Journal of Travel Medicine	2020	20
Sporozoite motility as a quantitative readout for anti-CSP antibody inhibition Clarize M. de Korne, Roos van Schuijlenburg, Jeroen Sijtsma, Scientific Reports	2022	20
Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial Geert V.T. Roozen, Roos van Schuijlenburg, A Hensen, Nature Medicine	2025	20
Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands Johan L. van der Plas, Vincent P. Kuiper, Wilhelmina Bagchus, The Lancet Infectious Diseases MalariaPharmacologyCausal Chemoprophylactic ActivityPlacebo-controlled StudyPharmacotherapy	2023	19
A Randomized Controlled Trial to Investigate Safety and Variability of Egg Excretion After Repeated Controlled Human Hookworm Infection Marie-Astrid Hoogerwerf, Jan Pieter R. Koopman, Jacqueline J. Janse, The Journal of Infectious Diseases	2020	15
Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development Yukiko Miyazaki, Catherin Marin-Mogollon, Takashi Imai, Frontiers in Cellular and Infection Microbiology	2020	14
Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trial Marie-Astrid Hoogerwerf, Jacqueline J. Janse, Vincent P. Kuiper, The Lancet Microbe	2023	13

Page 1